Backs FY25 adjusted EBITDA view $240M-$250M. The company said, “As a reminder, full-year 2025 results reflect a full year of legacy Acuren (TIC) operations and approximately five months of contribution from NV5 following the August 4, 2025 acquisition.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TIC: